These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 1380822)

  • 1. Expression of the tumour suppressor gene p53 in oral cancer.
    Langdon JD; Partridge M
    Br J Oral Maxillofac Surg; 1992 Aug; 30(4):214-20. PubMed ID: 1380822
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proliferative activity and loss of function of tumour suppressor genes as 'biomarkers' in diagnosis and prognosis of benign and preneoplastic oral lesions and oral squamous cell carcinoma.
    Girod SC; Pfeiffer P; Ries J; Pape HD
    Br J Oral Maxillofac Surg; 1998 Aug; 36(4):252-60. PubMed ID: 9762452
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunohistochemical detection of p53 and p63 in oral squamous cell carcinoma, oral leukoplakia, and oral submucous fibrosis.
    Varun BR; Ranganathan K; Rao UK; Joshua E
    J Investig Clin Dent; 2014 Aug; 5(3):214-9. PubMed ID: 23776093
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Accumulation of the p53 tumor-suppressor gene product in oral leukoplakia.
    Wood MW; Medina JE; Thompson GC; Houck JR; Min KW
    Otolaryngol Head Neck Surg; 1994 Dec; 111(6):758-63. PubMed ID: 7527509
    [TBL] [Abstract][Full Text] [Related]  

  • 5. p53 and Ki 67 expression in preneoplastic and neoplastic lesions of the oral mucosa.
    Girod SC; Krueger G; Pape HD
    Int J Oral Maxillofac Surg; 1993 Oct; 22(5):285-8. PubMed ID: 8245568
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heat shock protein and p53 expression in head and neck squamous cell carcinoma.
    Gandour-Edwards R; Trock BJ; Gumerlock P; Donald PJ
    Otolaryngol Head Neck Surg; 1998 May; 118(5):610-5. PubMed ID: 9591858
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oral lichen planus has a high rate of TP53 mutations. A study of oral mucosa in icelanD.
    Ogmundsdóttir HM; Hilmarsdóttir H; Astvaldsdóttir A; Jóhannsson JH; Holbrook WP
    Eur J Oral Sci; 2002 Jun; 110(3):192-8. PubMed ID: 12120703
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overexpression of p53 protein in betel- and tobacco-related human oral dysplasia and squamous-cell carcinoma in India.
    Kaur J; Srivastava A; Ralhan R
    Int J Cancer; 1994 Aug; 58(3):340-5. PubMed ID: 8050814
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overexpression of p53 is an early event in the tumorigenesis of oral squamous cell carcinomas.
    Shintani S; Yoshihama Y; Emilio AR; Matsumura T
    Anticancer Res; 1995; 15(2):305-8. PubMed ID: 7762998
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epithelial growth fraction and expression of p53 tumour suppressor gene in oral submucous fibrosis.
    Cox SC; Walker DM
    Aust Dent J; 1996 Apr; 41(2):91-6. PubMed ID: 8670041
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Coexpression of p53 and Ki 67 and lack of c-erbB2 expression in oral leukoplakias in India.
    Kumar P; Kane S; Rathod GP
    Braz Oral Res; 2012; 26(3):228-34. PubMed ID: 22641442
    [TBL] [Abstract][Full Text] [Related]  

  • 12. p53 expression in oral precancer and cancer.
    Rich AM; Kerdpon D; Reade PC
    Aust Dent J; 1999 Jun; 44(2):103-5. PubMed ID: 10452165
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of retinoic acid receptors in normal, dysplastic and malignant oral epithelia.
    Sherman JA; Partridge M
    Br J Oral Maxillofac Surg; 1997 Aug; 35(4):260-6. PubMed ID: 9291264
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of p53 mutant nuclear phosphoprotein in oral carcinoma and potentially malignant oral lesions.
    Warnakulasuriya KA; Johnson NW
    J Oral Pathol Med; 1992 Oct; 21(9):404-8. PubMed ID: 1432735
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The significance of PCNA and p53 protein in some oral tumors.
    Tsuji T; Mimura Y; Wen S; Li X; Kanekawa A; Sasaki K; Shinozaki F
    Int J Oral Maxillofac Surg; 1995 Jun; 24(3):221-5. PubMed ID: 7594756
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mutated and wild-type p53 expression and HPV integration in proliferative verrucous leukoplakia and oral squamous cell carcinoma.
    Gopalakrishnan R; Weghorst CM; Lehman TA; Calvert RJ; Bijur G; Sabourin CL; Mallery SR; Schuller DE; Stoner GD
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 1997 Apr; 83(4):471-7. PubMed ID: 9127380
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessment of p63 expression in oral squamous cell carcinomas and dysplasias.
    Bortoluzzi MC; Yurgel LS; Dekker NP; Jordan RC; Regezi JA
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2004 Dec; 98(6):698-704. PubMed ID: 15583543
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Elevated ras p21 expression in oral premalignant lesions and squamous cell carcinoma in Taiwan.
    Kuo MY; Chang HH; Hahn LJ; Wang JT; Chiang CP
    J Oral Pathol Med; 1995 Jul; 24(6):255-60. PubMed ID: 7562661
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Valuation of exfoliative cytology as prediction factor in oral mucosa lesions.
    Brunotto M; Zárate AM; Cismondi A; Fernández Mdel C; Noher de Halac RI
    Med Oral Patol Oral Cir Bucal; 2005 Jul; 10 Suppl 2():E92-102. PubMed ID: 15995578
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of overexpression of p53 oncoprotein with the state of cell proliferation in oral carcinoma.
    Warnakulasuriya KA; Johnson NW
    J Oral Pathol Med; 1994 Jul; 23(6):246-50. PubMed ID: 7932243
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.